D. E. Shaw & Co., Inc. Catalyst Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.18 - $17.11 $509,512 - $661,438	-38,658 Reduced 75.92%	12,261 $195,000
Q4 2023 Feb 14, 2024	SELL	$11.78 - $17.29 $1.19 Million - $1.75 Million	-101,149 Reduced 66.52%	50,919 $855,000
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $2.61 Million - $3.36 Million	-223,550 Reduced 59.52%	152,068 $1.78 Million
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $9.24 Million - $14.5 Million	-803,804 Reduced 68.15%	375,618 $5.05 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $6.37 Million - $9.36 Million	-444,544 Reduced 27.37%	1,179,422 $19.6 Million
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $2.95 Million - $4.7 Million	-241,059 Reduced 12.93%	1,623,966 $30.2 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $3.09 Million - $6.8 Million	437,975 Added 30.69%	1,865,025 $23.9 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $2.4 Million - $3.3 Million	385,083 Added 36.96%	1,427,050 $10 Million
Q1 2022 May 16, 2022	BUY	$5.31 - $8.31 $2.5 Million - $3.91 Million	470,180 Added 82.23%	1,041,967 $8.64 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $869,700 - $1.24 Million	166,929 Added 41.23%	571,787 $3.87 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $230,277 - $286,779	-47,480 Reduced 10.5%	404,858 $2.15 Million
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $1.3 Million - $1.83 Million	301,946 Added 200.77%	452,338 $2.6 Million
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $712,614 - $968,742	-206,555 Reduced 57.87%	150,392 $693,000
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $293,605 - $378,622	-98,857 Reduced 21.69%	356,947 $1.19 Million
Q3 2020 Nov 16, 2020	SELL	$2.97 - $5.08 $778,823 - $1.33 Million	-262,230 Reduced 36.52%	455,804 $1.35 Million
Q2 2020 Aug 14, 2020	SELL	$3.48 - $5.05 $405,639 - $588,643	-116,563 Reduced 13.97%	718,034 $3.32 Million
Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $600,722 - $1.2 Million	230,162 Added 38.08%	834,597 $3.21 Million
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $2.22 Million - $3.45 Million	604,435 New	604,435 $2.27 Million
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $62,772 - $118,352	-32,694 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.81 - $3.78 $65,832 - $88,557	-23,428 Reduced 41.74%	32,694 $124,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $119,386 - $202,851	-52,826 Reduced 48.49%	56,122 $175,000
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $9,082 - $15,238	3,800 Added 3.61%	108,948 $260,000
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $263,921 - $462,651	105,148	105,148 $411,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

Black Rock Inc. New York, NY

18.7M
Shares

$385 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

8.04M
Shares

$166 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

6.23M
Shares

$128 Million
2.3% of portfolio
State Street Corp Boston, MA

5.69M
Shares

$117 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.02M
Shares

$62.2 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account